The use of CRISPR interference (CRISPRi) to repress the expression of mutant with relative preservation of wild-type huntingtin may represent a potential therapeutic strategy to delay disease progression in a mouse model of Huntington’s disease.
- Jung Hwa Seo
- Jeong Hong Shin
- Sung-Rae Cho